References

REV7: a small but mighty regulator of genome maintenance and cancer development

2024 · External reference

10.1371/journal.pgen.1006842

10.1371/journal.pgen.1006842 · External reference

10.1002/em.22087

10.1002/em.22087 · External reference

The Immunohistochemical Expression of REV-7 in Various Human Cancer Pathology Specimens: A Systematic Review

2024 · External reference

REV7 Expression Is Associated with Tumor Cell Growth and Cisplatin Resistance in Gallbladder Adenocarcinoma

10.1159/000549588 · 2026 · External reference

Expression of REV7 has prognostic significance in cervical cancer treated with intensity-modulated radiation therapy

10.1007/s12672-025-02224-9 · 2025 · External reference

Elevated expression of REV7 correlates with poor prognosis in lung adenocarcinoma and its inactivation in carcinoma cells enhances chemosensitivity

10.1016/j.prp.2024.155779 · 2025 · External reference

Significance of REV7 Expression in p16-Negative Oropharyngeal Squamous Cell Carcinoma

10.1002/hed.28015 · 2025 · External reference

Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer

10.1186/s12935-020-01668-z · 2020 · External reference

Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction

10.1016/j.bmc.2016.07.026 · 2016 · External reference

Targeting MAD2L2-dependent translesion synthesis impairs DNA damage tolerance and enhances cellular response to cisplatin

10.3389/fcell.2026.1859193 · 2026 · External reference

Docking-Based Virtual Screening Identifies a Small-Molecule Inhibitor of the Translesion Synthesis REV7/REV3 Protein-Protein Interaction

10.1002/cmdc.70427 · 2026 · External reference

10.1038/s41586-018-0340-7

10.1038/s41586-018-0340-7 · External reference

10.4161/cc.23214

10.4161/cc.23214 · External reference

10.1080/15384101.2015.1120922

10.1080/15384101.2015.1120922 · External reference

10.1007/s00709-005-0137-z

10.1007/s00709-005-0137-z · External reference

10.1101/gad.897901

10.1101/gad.897901 · External reference

10.15252/embj.201591697

10.15252/embj.201591697 · External reference

10.1371/journal.pone.0007020

10.1371/journal.pone.0007020 · External reference

REV7 functions with REV3 as a checkpoint protein delaying mitotic entry until DNA replication is completed

10.1016/j.celrep.2025.115431 · 2025 · External reference

10.1002/med.20097

10.1002/med.20097 · External reference

10.1083/jcb.99.3.1066

10.1083/jcb.99.3.1066 · External reference

10.3390/proteomes11010003

10.3390/proteomes11010003 · External reference

10.1158/0008-5472.can-08-0002

10.1158/0008-5472.can-08-0002 · External reference

10.18632/oncotarget.5021

10.18632/oncotarget.5021 · External reference

10.1038/386623a0

10.1038/386623a0 · External reference

10.1007/s00280-005-0050-3

10.1007/s00280-005-0050-3 · External reference

10.1016/j.jss.2011.06.016

10.1016/j.jss.2011.06.016 · External reference

10.1126/science.8484122

10.1126/science.8484122 · External reference

10.1530/erc-17-0147

10.1530/erc-17-0147 · External reference

10.1016/j.sbi.2020.11.003

10.1016/j.sbi.2020.11.003 · External reference

10.1186/1476-4598-2-30

10.1186/1476-4598-2-30 · External reference

10.1007/s10577-015-9505-5

10.1007/s10577-015-9505-5 · External reference

10.7150/ijbs.7.1122

10.7150/ijbs.7.1122 · External reference

10.1002/(sici)1098-2264(200002)27:2<183::aid-gcc10>3.0.co;2-p

10.1002/(sici)1098-2264(200002)27:2<183::aid-gcc10>3.0.co;2-p · External reference

10.5483/bmbrep.2023-0025

10.5483/bmbrep.2023-0025 · External reference

10.1210/endocr/bqab208

10.1210/endocr/bqab208 · External reference

10.1016/s0960-9822(95)00276-4

10.1016/s0960-9822(95)00276-4 · External reference

10.1002/em.20532

10.1002/em.20532 · External reference

10.1038/cddis.2014.164

10.1038/cddis.2014.164 · External reference

10.1038/s44319-024-00260-0

10.1038/s44319-024-00260-0 · External reference

10.1091/mbc.e18-10-0651

10.1091/mbc.e18-10-0651 · External reference